Evaluation of Circulating Small Extracellular Vesicle-derived MiRNAs As Diagnostic Biomarkers for Differentiating Between Different Pathological Types of Early Lung Cancer

Overview

Journal Sci Rep

Specialty Science

Date 2022 Oct 13

PMID 36229645

Authors

Yi-Fang Jiang

Shan-Na Wei

Nan Geng

Wen-Wen Qin

Xin He

Xiu-Huan Wang

Yao-Pu Qi

Shan Song

Ping Wang

Affiliations

Soon will be listed here.

Abstract

Lung cancer is the leading cause of cancer-related death worldwide. MicroRNAs (miRNAs) in circulating small extracellular vesicles (sEVs) have been suggested to be potential biomarkers for cancer diagnosis. The present study was designed to explore whether plasma-derived sEV miRNAs could be utilized as diagnostic biomarkers for differentiating between early-stage small cell lung cancer (SCLC) and early-stage non-small cell lung cancer (NSCLC). We compared the miRNA profiles of plasma-derived sEVs from healthy individuals, patients with early-stage SCLC and patients with early-stage NSCLC. Next-generation sequencing was used to screen for differentially expressed miRNAs (DEMs). Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were used to predict the potential functions of these DEMs. Weighted gene coexpression network analysis (WGCNA) was used to identify the different pathology-related miRNA modules. We found that 22 DEMs were significantly different among healthy individuals, patients with early-stage SCLC, and patients with early-stage NSCLC. We selected six representative DEMs for validation by qRT‒PCR, which confirmed that miRNA-483-3p derived from plasma sEVs could be used as a potential biomarker for the diagnosis of early-stage SCLC, miRNA-152-3p and miRNA-1277-5p could be used for the diagnosis of early-stage NSCLC respectively.

Citing Articles

A comparative analysis of small extracellular vesicle (sEV) micro-RNA (miRNA) isolation and sequencing procedures in blood plasma samples.

Abeysinghe P, Turner N, Mitchell M Extracell Vesicles Circ Nucl Acids. 2024; 5(1):119-137.

PMID: 39698410 PMC: 11648519. DOI: 10.20517/evcna.2023.55.

Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC.

Bafiti V, Thanou E, Ouzounis S, Kotsakis A, Georgoulias V, Lianidou E Cancers (Basel). 2024; 16(22).

PMID: 39594687 PMC: 11592109. DOI: 10.3390/cancers16223729.

Comparing preprocessing strategies for 3D-Gene microarray data of extracellular vesicle-derived miRNAs.

Takemoto Y, Ito D, Komori S, Kishimoto Y, Yamada S, Hashizume A BMC Bioinformatics. 2024; 25(1):221.

PMID: 38902629 PMC: 11188187. DOI: 10.1186/s12859-024-05840-4.

The Role of Biomarkers in Lung Cancer Screening.

Boutsikou E, Hardavella G, Fili E, Bakiri A, Gaitanakis S, Kote A Cancers (Basel). 2024; 16(11).

PMID: 38893101 PMC: 11171002. DOI: 10.3390/cancers16111980.

A plasma miRNA-based classifier for small cell lung cancer diagnosis.

Saviana M, Romano G, McElroy J, Nigita G, Distefano R, Toft R Front Oncol. 2023; 13:1255527.

PMID: 37869089 PMC: 10585112. DOI: 10.3389/fonc.2023.1255527.

References

Kalemkerian G, Loo B, Akerley W, Attia A, Bassetti M, Boumber Y . NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018; 16(10):1171-1182. DOI: 10.6004/jnccn.2018.0079. View

Cochetti G, Cari L, Nocentini G, Maula V, Suvieri C, Cagnani R . Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma. Sci Rep. 2020; 10(1):21290. PMC: 7718885. DOI: 10.1038/s41598-020-77774-9. View

Alexandre D, Teixeira B, Rico A, Valente S, Craveiro A, Baptista P . Molecular Beacon for Detection miRNA-21 as a Biomarker of Lung Cancer. Int J Mol Sci. 2022; 23(6). PMC: 8955680. DOI: 10.3390/ijms23063330. View

Tao L, Pan X, Wang J, Zhang L, Tao L, Liang C . Circular RNA circANKS1B acts as a sponge for miR-152-3p and promotes prostate cancer progression by upregulating TGF-α expression. Prostate. 2021; 81(5):271-278. DOI: 10.1002/pros.24102. View

Aliotta J, Pereira M, Johnson K, De Paz N, Dooner M, Puente N . Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp Hematol. 2010; 38(3):233-45. PMC: 2829939. DOI: 10.1016/j.exphem.2010.01.002. View

Lee R, Feinbaum R, Ambros V . The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75(5):843-54. DOI: 10.1016/0092-8674(93)90529-y. View

Kalluri R, LeBleu V . The biology function and biomedical applications of exosomes. Science. 2020; 367(6478). PMC: 7717626. DOI: 10.1126/science.aau6977. View

Vasuri F, Fittipaldi S, De Pace V, Gramantieri L, Bertuzzo V, Cescon M . Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas. Oncotarget. 2018; 9(25):17895-17905. PMC: 5915163. DOI: 10.18632/oncotarget.24860. View

Rodrigues-Junior D, Tan S, de Souza Viana L, Carvalho A, Lim S, Iyer N . A preliminary investigation of circulating extracellular vesicles and biomarker discovery associated with treatment response in head and neck squamous cell carcinoma. BMC Cancer. 2019; 19(1):373. PMC: 6480898. DOI: 10.1186/s12885-019-5565-9. View

10.

Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing C . Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg. 2010; 14(7):1170-9. DOI: 10.1007/s11605-010-1202-2. View

11.

Lempriere S . Plasma miRNAs as candidate biomarkers of CMT. Nat Rev Neurol. 2021; 17(7):394. DOI: 10.1038/s41582-021-00521-9. View

12.

Masliah-Planchon J, Garinet S, Pasmant E . RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action. Oncotarget. 2015; 7(25):38892-38907. PMC: 5122439. DOI: 10.18632/oncotarget.6476. View

13.

Wang Z, Zhang C, Chang J, Tian X, Zhu C, Xu W . LncRNA EMX2OS, Regulated by TCF12, Interacts with FUS to Regulate the Proliferation, Migration and Invasion of Prostate Cancer Cells Through the cGMP-PKG Signaling Pathway. Onco Targets Ther. 2020; 13:7045-7056. PMC: 7398891. DOI: 10.2147/OTT.S243552. View

14.

Shahverdi M, Hajiasgharzadeh K, Daei Sorkhabi A, Jafarlou M, Shojaee M, Jalili Tabrizi N . The regulatory role of autophagy-related miRNAs in lung cancer drug resistance. Biomed Pharmacother. 2022; 148:112735. DOI: 10.1016/j.biopha.2022.112735. View

15.

MotieGhader H, Kouhsar M, Najafi A, Sadeghi B, Masoudi-Nejad A . mRNA-miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation. Mol Biosyst. 2017; 13(10):2168-2180. DOI: 10.1039/c7mb00400a. View

16.

Dixon C, Sheller-Miller S, Saade G, Fortunato S, Lai A, Palma C . Amniotic Fluid Exosome Proteomic Profile Exhibits Unique Pathways of Term and Preterm Labor. Endocrinology. 2018; 159(5):2229-2240. PMC: 6963707. DOI: 10.1210/en.2018-00073. View

17.

Wang H, Liu J, Li J, Zang D, Wang X, Chen Y . Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis. Cancer Genet. 2020; 242:1-7. DOI: 10.1016/j.cancergen.2020.01.052. View

18.

Ma P, Li L, Liu F, Zhao Q . HNF1A-Induced lncRNA HCG18 Facilitates Gastric Cancer Progression by Upregulating DNAJB12 via miR-152-3p. Onco Targets Ther. 2020; 13:7641-7652. PMC: 7413704. DOI: 10.2147/OTT.S253391. View

19.

Zhang M, Liu D, Li W, Wu X, Gao C, Li X . Identification of featured biomarkers in breast cancer with microRNA microarray. Arch Gynecol Obstet. 2016; 294(5):1047-1053. DOI: 10.1007/s00404-016-4141-7. View

20.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View